Concepedia

Eduard Felder

EF

Statistics

Publications

39

Citations

3.4K

H-Index

24

Active since

1984

Affiliations

Nerviano Medical Sciences(Current)

Novartis (Switzerland)

Los Alamos National Laboratory

University of California San Diego

Board of the Swiss Federal Institutes of Technology

Eduard Felder is an author at Nerviano Medical Sciences specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

1984–2019

39

Publications

39

The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm et al. · Science · 2017 · 871 citations · Full text

, , +15

Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 312 citations · Full text

, , +17

Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor

Maria Menichincheri, Elena Ardini, Paola Magnaghi et al. · Journal of Medicinal Chemistry · 2016 · 298 citations · Full text

, , +17

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

François Hamy, Eduard Felder, Gerhard Heizmann et al. · Proceedings of the National Academy of Sciences · 1997 · 242 citations

, , +13

Massive electron state in YbBiPt

Z. Fisk, P. C. Canfield, W. P. Beyermann et al. · Physical Review Letters · 1991 · 185 citations · Full text

, , +16

1–5 of 39